Investing.com -- Raymond James has updated its Healthcare Top Picks list for October, adding three new stocks while removing others from the monthly selection. The firm added Xencor, Calyxt, and UnitedHealth Group to replace Relay Therapeutics, Tyra Biosciences, and Oscar Health.

Oscar Health, Inc. (OSCR) reached $29.9 at the closing of the latest trading day, reflecting a -3.05% change compared to its last close.

Corient Private Wealth LP lowered its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 83.7% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 18,589 shares of the company

Oscar Health, Inc. (NYSE:OSCR - Obtenga informe gratuito) recibió una calificación de consenso de "Mantener" de las trece firmas calificadoras que actualmente cubren la acción, informa MarketBeat.com. Un analista de investigación calificó la acción con una recomendación de venta, ocho le dieron una recomendación de mantener, tres

Tesis de compra de Oscar Health (OSCR): valor razonable de $ 45 a $ 49 sobre el crecimiento de ACA, la mejora de los márgenes y la ventaja de Lucie.

WOOF, FIVE and OSCR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 25th, 2026.